Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model
Launched by URAL TELEKOMUNIKASYON SANAYI TICARET ANONIM SIRKETI · Mar 15, 2021
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
This is a prospective study to assess the safety and efficacy of EyeCheckup in screening for DR.
This study was carried out in a single center at Akdeniz University Faculty of Medicine with primary endpoints to determine the sensitivity and specificity of EyeCheckup to diabetic retinopathy in the primary care setting.
Methods and tools to be used in the study:
* Fundus photography with non-mydriatic camera and classification of diabetic retinopathy with artificial intelligence algorithm,
* Evaluation of seven field dilated fundus images by retina specialists and comparison of results for...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A diagnosis of diabetes mellitus
- • Understanding of study and provision of written informed consent
- • 18 years of age or older
- • No history of any other retinal vascular disease, glaucoma, or other disease that may affect the appearance of the retina or optic disc (refractive error and ocular surface disease are allowed)
- • Other than cataract surgery, no history of intraocular surgery, ocular laser treatments for any retinal disease, or ocular injections for diabetic macular edema or proliferative disease No media opacity precluding good retinal photography
- Exclusion Criteria:
- • No diagnosis of diabetes mellitus
- • Potential subject cannot understand study or informed consent
- • A history of retinal vascular disease other than diabetic retinopathy that may affect the appearance of the retina or optic disc
- • Previous intraocular surgery including cataract; previous laser to the retina; or previous intraocular injections for the treatment of diabetic retinopathy
- • Pregnant women or women with gestational diabetes mellitus
- • A media opacity in either eye that is severe enough to preclude good retinal photography
- • Permanent vision impairment in one or both eyes
- * The participant is contraindicated for imaging with fundus imaging systems used in the study:
- • Participant is hypersensitive to light
- • Participant recently received photodynamic therapy (PDT)
- • Participant uses drugs that cause photosensitivity
About Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi
Ural Telekomunikasyon Sanayi Ticaret Anonim Şirketi is a forward-thinking telecommunications company dedicated to advancing communication technologies and services. With a strong emphasis on innovation and quality, the company is committed to conducting clinical trials that explore the intersection of telecommunications and healthcare. By leveraging cutting-edge technology and expertise, Ural Telekom aims to enhance patient outcomes and streamline healthcare delivery through its research initiatives. The organization prioritizes ethical standards and regulatory compliance, ensuring that all clinical trials contribute valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Antalya, , Turkey
Patients applied
Trial Officials
A Burak Bilgin, Assoc. Prof.
Principal Investigator
Instructor, Retinal Surgeon, Academic Advisor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials